TBPH Cash & Equivalents
Theravance Biopharma Inc · Cash & Equivalents
TBPH Cash & Equivalents
Latest reported$167.81Mperiod ending
TBPH FY Cash & Equivalents ($0.00 → $167.81M)
Annual Cash & Equivalents
High-resolution chart · PNG
TBPH cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 167,806,000 | |
| 37,797,000 | |
| 39,545,000 | |
| 298,172,000 | |
| 89,959,000 | |
| 81,467,000 | |
| 58,064,000 | |
| 378,021,000 | |
| 88,980,000 | |
| 344,709,000 | |
| 112,707,000 | |
| 89,215,000 | |
| 0 | |
| 0 | |
| 0 |